Sign In

Jennifer Lam, PhD, MPH

People

Kaiser Permanente Division of Research
2000 Broadway
Oakland, CA 94612

(510) 891-3438 (phone)
jennifer.o.lam@kp.org


Jennifer Lam, PhD, MPH, is a Staff Scientist at the Kaiser Permanente Northern California Division of Research. She received her bachelor's in English from the University of California, Berkeley, and both her master's in Public Health and doctorate in Epidemiology and International Health from Johns Hopkins University.

Dr. Lam has a background in the surveillance and epidemiology of infectious diseases, with a focus on HIV, HPV, and vaccine-preventable diseases. Her current research interests include substance use, chronic diseases, cancer and aging-related conditions in people with HIV.


Current Position(s):

  • Staff Scientist, Division of Research, Kaiser Permanente Northern California

Section Affiliations:

Primary Research Interests:

  • HIV and aging
  • Dementia and cognitive impairment
  • Infection-associated cancers
  • Infectious disease epidemiology

    Electronic Health Record-Based Dementia Prediction for HIV Primary Care

    The goal of this K01 Career Development Award is to receive mentored training on the development of risk prediction models for dementia in people with HIV using electronic health records data. The project will quantify the contribution of HIV- and non-HIV-related factors to risk of dementia; develop and validate a model to predict incident dementia in people with HIV; and investigate strategies to optimize translation and implementation of research findings into clinical care settings.
    Investigator: Lam, Jennifer
    Funder: National Institute of Allergy and Infectious Diseases

    Neurocognitive Impairment and Dementia in People With and Without HIV

    People with HIV are at increased risk for dementia due to the combined effects of HIV-associated inflammation and traditional (non-HIV) risk factors such as chronic drug use and cerebrovascular disease. With the widespread use of antiretroviral therapy for the treatment of HIV infection, severe forms of HIV-associated dementia are now uncommon, but milder forms of neurocognitive impairment remain a persistent concern, potentially affecting up to 50% of people living with HIV. In preparation for future investigations on cognitive dysfunction in people aging with HIV, we are conducting a study to establish baseline knowledge on: 1) The prevalence of neurocognitive impairment and dementia, and 2) Risk factors for neurocognitive disorders among Kaiser Permanente Northern California patients with HIV compared to patients without HIV.
    Investigator: Lam, Jennifer
    Funder: Northern California Community Benefit Programs
    No results found matching criteria

    Comparison of dementia incidence and prevalence between individuals with and without HIV infection in primary care from 2000 to 2016

    Author(s): Lam JO; Lee C; Gilsanz P; Hou CE; Leyden WA; Satre DD; Flamm JA; Towner WJ; Horberg MA; Silverberg MJ

    AIDS. 2021 Nov 24.

    PubMed abstract

    Cancer in people with and without hepatitis C virus infection: comparison of risk before and after introduction of direct-acting antivirals

    Author(s): Lam JO; Quesenberry CP; Silverberg MJ; et al.

    Cancer Epidemiol Biomarkers Prev. 2021 Sep 28.

    PubMed abstract

    The relationship of smoking and unhealthy alcohol use to the HIV care continuum among people with HIV in an integrated health care system

    Author(s): Satre DD; Sterling SA; Young-Wolff KC; Lam JO; Alexeeff S; Hojilla JC; Weisner C; Silverberg MJ; et al.

    Drug Alcohol Depend. 2021 Feb 01;219:108481. Epub 2021-01-08.

    PubMed abstract

    Comparison of dementia risk after age 50 between individuals with and without HIV infection

    Author(s): Lam JO; Hou CE; Hojilla JC; Anderson AN; Gilsanz P; Alexeeff SE; Levine-Hall T; Hood N; Lee C; Satre DD; Silverberg MJ

    AIDS. 2020 Dec 30;Publish Ahead of Print. Epub 2020-12-30.

    PubMed abstract

    Health System-Based Unhealthy Alcohol Use Screening and Treatment Comparing Demographically-Matched Participants With and Without HIV

    Author(s): Silverberg MJ; Alexeeff SE; Lam JO; Weisner CM; Sterling SA; Satre DD; et al.

    Alcohol Clin Exp Res. 2020 Oct 17.

    PubMed abstract

    Smoking and cessation treatment among persons with and without HIV in a U.S. integrated health system

    Author(s): Lam JO; Levine-Hall T; Hood N; Alexeeff SE; Horberg MA; Young-Wolff KC; Sterling SA; Williams A; Weisner C; Satre DD; Silverberg MJ

    Drug Alcohol Depend. 2020 Aug 01;213:108128. Epub 2020-06-18.

    PubMed abstract

    Comparison of Overall and Comorbidity-Free Life Expectancy Between Insured Adults With and Without HIV Infection, 2000-2016

    Author(s): Marcus JL; Leyden WA; Alexeeff SE; Anderson AN; Hechter RC; Hu H; Lam JO; Towner WJ; Yuan Q; Horberg MA; Silverberg MJ

    JAMA Netw Open. 2020 Jun 01;3(6):e207954. Epub 2020-06-01.

    PubMed abstract

    Effectiveness of 'catch-up' human papillomavirus vaccination to prevent cervical neoplasia in immunosuppressed and non-immunosuppressed women

    Author(s): Silverberg MJ; Leyden WA; Lam JO; Chao CR; Gregorich SE; Huchko MJ; Kulasingam S; Kuppermann M; Smith-McCune KK; Sawaya GF

    Vaccine. 2020 Jun 15;38(29):4520-4523. Epub 2020-05-20.

    PubMed abstract

    Colorectal Cancer Screening in People With and Without HIV in an Integrated Health Care Setting

    Author(s): Lam JO; Hurley LB; Udaltsova N; Alexeeff SE; Klein DB; Corley DA; Silverberg MJ

    J Acquir Immune Defic Syndr. 2019 Jul 01;81(3):284-291.

    PubMed abstract

    Interventions to Reduce Unhealthy Alcohol Use among Primary Care Patients with HIV: the Health and Motivation Randomized Clinical Trial

    Author(s): Satre DD; Leibowitz AS; Leyden W; Lam JO; Weisner CM; Sterling SA; Silverberg MJ; et al.

    J Gen Intern Med. 2019 Jun 11.

    PubMed abstract

    Hepatitis C treatment uptake and response among human immunodeficiency virus/hepatitis C virus-coinfected patients in a large integrated healthcare system.

    Author(s): Lam, Jennifer O JO; Hurley, Leo B LB; Chamberland, Scott S; Champsi, Jamila H JH; Gittleman, Laura C LC; Korn, Daniel G DG; Lai, Jennifer B JB; Quesenberry, Charles P CP; Ready, Joanna J; Saxena, Varun V; Seo, Suk I SI; Witt, David J DJ; Silverberg, Michael J MJ; Marcus, Julia L JL

    International journal of STD & AIDS. 2019 Jun ;30(7):689-695. Epub 2019-05-02.

    PubMed abstract

    Early outcomes of a high-resolution anoscopy-based anal cancer screening program among people with HIV enrolled in an integrated healthcare system

    Author(s): Barnell GM; Merchant M; Lam JO; Silverberg MJ

    J Acquir Immune Defic Syndr. 2019 Mar 29.

    PubMed abstract

    Effectiveness of catch-up human papillomavirus vaccination on incident cervical neoplasia in a US health-care setting: a population-based case-control study

    Author(s): Silverberg MJ; Leyden WA; Lam JO; Gregorich SE; Huchko MJ; Kulasingam S; Kuppermann M; Smith-McCune KK; Sawaya GF

    Lancet Child Adolesc Health. 2018 Oct;2(10):707-714. Epub 2018-08-08.

    PubMed abstract

    Acceptability of high-resolution anoscopy for anal cancer screening in HIV-infected patients

    Author(s): Lam JO; Barnell GM; Merchant M; Ellis CG; Silverberg MJ

    HIV Med. 2018 Aug 06.

    PubMed abstract

    Disparities in Initiation of Direct-Acting Antiviral Agents for Hepatitis C Virus Infection in an Insured Population.

    Author(s): Marcus JL; Lam JO; Quesenberry CP; Silverberg MJ; et al.

    Public health reports (Washington, D.C. : 1974). 2018 Jan 01;():33354918772059. Epub 2018-01-01.

    PubMed abstract